Get started
RocketTickers

Merck Announces Positive Top-Line Results from Pivotal Phase 3 T

Long
Merck & Company, Inc. (NYSE:MRK)  
RocketTickers  
NYSE:MRK   Merck & Company, Inc.
Beyond Technical Analysis
0
0
beyondta
MRK: Merck & Co., Inc.
2021-10-25 06:45:00
Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.